Sensorium Therapeutics
Pranav Tadi has worked in various roles in the finance and corporate development sector since 2011. Pranav began their career as a Research Associate at UCSF Medical Center in 2011, followed by a role as a High School Algebra & Geometry Teacher at Fremont High School (Teach For America) in 2013. In 2014, they were a Strategic Financial Analyst at DaVita Rx. From 2015 to 2021, they worked at Indigo in various roles, including Director, Corporate Development, Senior Manager, Corporate Development, Manager - Strategic Finance & Corporate Development, Senior Associate - Strategic Finance & Corporate Development, and Associate - Finance & Business Operations. Currently, they are the VP, Head of Finance at Sensorium Therapeutics.
Pranav Tadi attended Whitney High School and earned their High School Diploma. Pranav then attended the University of California, Berkeley and obtained a degree in Molecular and Cell Biology with a focus in Cell & Developmental Biology. Finally, they attended Harvard Business School and obtained a Master of Business Administration (MBA).
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.